{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:21:19Z","timestamp":1789050079720,"version":"build-2803163510"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"\n Importance<\/jats:title>\n Clesrovimab is a long-acting monoclonal antibody approved for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season; data concerning clesrovimab from a second RSV season among children who remain at risk for severe disease are needed.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the safety and tolerability of clesrovimab (105 mg) vs palivizumab in RSV season 1 in infants at increased risk for severe RSV disease. Key secondary objectives include describing the safety of 210 mg of clesrovimab in RSV season 2 in children who remain at increased risk for severe RSV disease, clesrovimab pharmacokinetics, and the incidence of RSV-associated disease.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n SMART (MK-1654-007) was a randomized, partially masked, palivizumab-controlled, phase 3 clinical trial, conducted at 110 sites in 27 countries and territories between November 30, 2021, and November 20, 2025. The population constituted palivizumab-eligible infants, including those with prematurity, chronic lung disease of prematurity, or hemodynamically significant congenital heart disease.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants, randomized 1:1 and stratified by region and condition, received clesrovimab (105 mg) on day 1 followed by placebo on day 28 or monthly palivizumab (15 mg\/kg) up to 5 doses (1 dose per month). Eligible infants received open-label clesrovimab (210 mg) before their second RSV season.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the observed proportions of participants experiencing adverse events (AEs) after clesrovimab or palivizumab in season 1.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Overall, 997 infants (500 [50.2%] male; median age, 2.6 [range, 0.0-12.0] months) received clesrovimab, 105 mg (n\u2009=\u2009498) or palivizumab (n\u2009=\u2009499) in season 1; 276 received clesrovimab, 210 mg open-label in season 2. In season 1, the proportions of participants experiencing AEs were comparable between treatment groups. In season 2, clesrovimab, 210 mg was well tolerated. Incidence rates of RSV-associated medically attended lower respiratory infection (MALRI) were comparable between clesrovimab and palivizumab (3.2% [95% CI, 1.8%-5.2%] and 3.4% [95% CI, 2.0%-5.6%], respectively) through day 150 in season 1; total RSV-associated MALRI incidence through day 180 after a 210-mg dose in season 2 was 7.3% (95% CI, 4.4%-11.4%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, clesrovimab was well tolerated in infants at increased risk for severe RSV disease through 2 RSV seasons. These findings support the use of clesrovimab in children who remain at risk for severe RSV disease in their second RSV season.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04938830<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2026.2760","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:30:30Z","timestamp":1784561430000},"page":"951","source":"Crossref","is-referenced-by-count":3,"title":["Clesrovimab in Infants at Increased Risk For Severe Disease During 2 RSV Seasons"],"prefix":"10.1001","volume":"180","author":[{"given":"Heather J.","family":"Zar","sequence":"first","affiliation":[{"name":"Department of Paediatrics & Child Health and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Bont","sequence":"additional","affiliation":[{"name":"UMC Utrecht, Utrecht, the Netherlands"},{"name":"ReSViNET Foundation, Zeist, the Netherlands"},{"name":"Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Manzoni","sequence":"additional","affiliation":[{"name":"University Hospital Degli Infermi, Ponderano, Italy"},{"name":"Univeristy of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[{"name":"St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yen","family":"Chen","sequence":"additional","affiliation":[{"name":"Taichung Veterans General Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"Novoa","sequence":"additional","affiliation":[{"name":"Hospital Padre Alberto Hurtado, Santiago, Chile"},{"name":"Faculty of Medicine, Universidad del Desarrollo, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo A.","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[{"name":"Universidad Del Valle, Cali, Colombia"},{"name":"Cl\u00ednica Imbanaco, Cali, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsolia","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Athens, Greece"},{"name":"P. and A. Kyriakou Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Tapi\u00e9ro","sequence":"additional","affiliation":[{"name":"CHU Sainte-Justine, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta I.","family":"Acu\u00f1a-\u00c1vila","sequence":"additional","affiliation":[{"name":"Hospital Roberto del R\u00edo, Santiago, Chile"},{"name":"Centro de Investigaci\u00f3n Cl\u00ednica Avanzada, Facultad de Medicina, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier M.","family":"Castellanos","sequence":"additional","affiliation":[{"name":"Morales Vargas Centro de Investigaci\u00f3n, Le\u00f3n, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Meyer","sequence":"additional","affiliation":[{"name":"Middlemore Hospital, Auckland, New Zealand"},{"name":"University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[{"name":"Nihon University Itabashi Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santtu","family":"Heinonen","sequence":"additional","affiliation":[{"name":"University of Helsinki, Helsinki, Finland"},{"name":"FVR\u2013Finnish Vaccine Research, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zeng","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha A.","family":"Railkar","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Sofia","family":"Arriola","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zang","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hildebrand","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvino","family":"Maestri","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Castagnini","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushua","family":"Sinha","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SMART (MK-1654-007) study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pita","family":"Birch","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Tapiero","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Mitchell","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Novoa Pizarro","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta Isabel","family":"Acuna","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Maturana","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"D'Amato","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Ordonez","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Ricardo","family":"Bachiller","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristella","family":"Ayala","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbynek","family":"Stranak","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Wiedermannova","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santtu","family":"Heinonen","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Valimaa","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Brouard","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Lecorps","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandavi","family":"Rajguru","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tandonnet","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Thome","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ruediger","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wetzke","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Stiller","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elpis","family":"Hatziagorou","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Michos","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsolia","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Papaevangelou","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis Kam Lun","family":"Hon","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oi Yin","family":"Wong","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Dicso","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Kovacs","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Talosi","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Nador","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Ablonczy","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Boross","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Szegeny","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Karoly","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Szucs","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Buonsenso","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Cutrera","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Baraldi","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ronchi","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna Maria Roberta","family":"Esposito","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zempei","family":"Kano","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Isayama","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kanda","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Kajikawa","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Hee","family":"Chieng","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Binti","family":"Daud","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwi Sing Kwi","family":"Seah","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia Tuang","family":"Koh","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiah","family":"Kassim","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehala Devi","family":"Baskaran","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrain Montano","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Jimenez","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Rodriguez Weber","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Najera","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Moises","family":"Castellanos Martinez","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Meyer","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haavard Ove","family":"Skjerven","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildauro","family":"Aguirre S.","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy Leonel","family":"Prado Gomez","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe M.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee Thai","family":"Yeo","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthonet Lombard","family":"Koen","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun Lawrence","family":"Barnabas","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moherndran","family":"Archary","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buhle","family":"Nxumalo-Toba","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem Hassan","family":"Walele","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe Taryn","family":"Franckling-Smith","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather Joy","family":"Zar","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ares Segura","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blazquez Gamero","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fortuny Guasch","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Ramon","family":"Baca Cots","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep-Lluis","family":"Arimany Montana","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Ginovart Galiana","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cabanas Gonzalez","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Fernandez Colomer","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Huang","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin","family":"Chi","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chi","family":"Hsu","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yen","family":"Chen","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamolwish","family":"Laoprasopwattana","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supattra","family":"Rungmaitree","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Ulukol","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhur Sirvan","family":"Cetin","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Alabaz","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eray Esra","family":"Onal","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuat Emre","family":"Canpolat","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Johnson","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleri","family":"Adams","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McNamara","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Princess","family":"Galiza","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.F.","family":"Ho","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott Robert","family":"Dobson","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Lynn","family":"Nayak","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Odom","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Pillai","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Hornik","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Sabogal","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Eduardo","family":"Fergie","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dynio","family":"Honrubia","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Mcgill-Vargas","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Willis","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Parikh","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Espinosa","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin Wei-Hong","family":"Chan","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarak J.","family":"Patel","sequence":"additional","affiliation":[{"name":"for the SMART (MK-1654-007) study group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10340","key":"poi260039r1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"poi260039r2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children.","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med"},{"issue":"10433","key":"poi260039r3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(24)00138-7","article-title":"Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.","volume":"403","author":"Wang","year":"2024","journal-title":"Lancet"},{"key":"poi260039r4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1874285801105010144","article-title":"Risk factors for severe respiratory syncytial virus lower respiratory tract infection.","volume":"5","author":"Sommer","year":"2011","journal-title":"Open Microbiol J"},{"issue":"3","key":"poi260039r5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062574","article-title":"Respiratory syncytial virus-associated hospitalizations among children <5 years old: 2016 to 2020.","volume":"153","author":"Curns","year":"2024","journal-title":"Pediatrics"},{"issue":"6","key":"poi260039r6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid.","volume":"137","author":"Boyce","year":"2000","journal-title":"J Pediatr"},{"issue":"5","key":"poi260039r7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/INF.0000000000001357","article-title":"Comparing first- and second-year palivizumab prophylaxis in patients with hemodynamically significant congenital heart disease in the CARESS database (2005-2015).","volume":"36","author":"Li","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"poi260039r8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13052-015-0203-x","article-title":"Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV).","volume":"41","author":"Bollani","year":"2015","journal-title":"Ital J Pediatr"},{"issue":"9","key":"poi260039r9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants.","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"poi260039r10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants.","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"poi260039r12","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants.","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"poi260039r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115851","article-title":"Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults.","volume":"169","author":"Phuah","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"poi260039r14","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1038\/s41467-019-12137-1","article-title":"A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.","volume":"10","author":"Tang","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"poi260039r15","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1038\/s41598-019-40387-y","article-title":"Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015-17.","volume":"9","author":"Lu","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"poi260039r16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175792","article-title":"Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV\/A and RSV\/B.","volume":"12","author":"Hause","year":"2017","journal-title":"PLoS One"},{"issue":"45","key":"poi260039r17","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1016\/j.vaccine.2018.09.056","article-title":"Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset.","volume":"36","author":"Mas","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"poi260039r18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/irv.12727","article-title":"Characterization of human respiratory syncytial virus (RSV) isolated from HIV-exposed-uninfected and HIV-unexposed infants in South Africa during 2015-2017.","volume":"14","author":"Liu","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"issue":"13","key":"poi260039r20","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1056\/NEJMoa2502984","article-title":"Clesrovimab for prevention of RSV disease in healthy infants.","volume":"393","author":"Zar","year":"2025","journal-title":"N Engl J Med"},{"key":"poi260039r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2025.107995","article-title":"Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: comprehensive rationale and study design for the late-stage clinical trials.","volume":"157","author":"Sinha","year":"2025","journal-title":"Contemp Clin Trials"},{"issue":"13","key":"poi260039r23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMc2506107","article-title":"Clesrovimab in infants and children at increased risk for severe RSV disease.","volume":"393","author":"Zar","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"poi260039r24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/cpdd.883","article-title":"A phase 1 randomized, double-blind, placebo-controlled trial to assess the safety, tolerability, and pharmacokinetics of a respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy adults.","volume":"10","author":"Aliprantis","year":"2021","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"2","key":"poi260039r25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates.","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"issue":"2","key":"poi260039r26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/oxfordjournals.aje.a115507","article-title":"A simple method to calculate the confidence interval of a standardized mortality ratio (SMR).","volume":"131","author":"Ulm","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"1","key":"poi260039r27","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1038\/s41467-024-47757-9","article-title":"Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic.","volume":"15","author":"Rios-Guzman","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"poi260039r30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/cpt.70199","article-title":"Population pharmacokinetics of clesrovimab in preterm and full-term infants.","volume":"119","author":"Hu","year":"2026","journal-title":"Clin Pharmacol Ther"},{"key":"poi260039r29","author":"Aimin Tang","year":"2025"},{"key":"poi260039r11","unstructured":"FDA. FDA approves new drug to prevent RSV in babies and toddlers. July 17, 2023. Accessed February 11, 2026. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-drug-prevent-rsv-babies-and-toddlers"},{"key":"poi260039r19","unstructured":"Efficacy and safety of clesrovimab (MK-1654) in infants (MK-1654-004) (CLEVER). ClinicalTrials.gov identifier: NCT04767373. Updated February 11, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04767373"},{"key":"poi260039r21","unstructured":"Clesrovimab (MK-1654) in infants and children at increased risk for severe respiratory syncytial virus (RSV) disease (MK-1654-007) (SMART). ClinicalTrials.gov identifier: NCT04938830. Updated May 8, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04938830"},{"key":"poi260039r28","unstructured":"US Center for Disease Control (CDC) RSV-NET. May 5, 2025. Accessed February 11, 2026. https:\/\/www.cdc.gov\/rsv\/php\/surveillance\/rsv-net.html"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2851770\/jamapediatrics_zar_2026_oi_260039_1787759706.86796.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:01:03Z","timestamp":1788879663000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2851770"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.2760","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}